NEUWERK advises Mayd on $15M seed Financing

Hamburg - On October 14, 2021, Berlin-based Mayd announced it has raised $15 million in seed financing to advance its medicine delivery platform.

Mayd has spied an opportunity to build out a delivery platform in Europe which partners with the small-scale pharmacies that tend to be the norm on the continent, capitalizing on how the pandemic has generally accelerated demand for on-demand delivery.

The startup, which was only founded at the beginning of the year, has bagged €13 million ($15 million) in seed funding from 468 Capital, Earlybird and Target Global to build out its vision of delivering meds to Europeans’ doors fast — within 30 minutes if they’re ordered before midnight (or the next day, at a selected slot starting from 8 a.m.).

NEUWERK advised Mayd on the transaction.

For more information, please see Mayd's press release.

Advisors for Mayd:

NEUWERK, Hamburg

Kirsten Seeger (partner Corporate/M&A)

Daniel Meyer (Associate)

About NEUWERK:  NEUWERK was founded in 2016 by lawyers from Freshfields Bruckhaus Deringer and ROXIN in Hamburg. NEUWERK brings together specialists from the fields of labor law, corporate law/M&A, IP/IT, real estate law, litigation and white-collar criminal law/criminal compliance.

Press contact: For further questions please contact Dr. Sebastian Naber (sebastian.naber@neuwerk.legal), T +49 40 340 5757-30.

NEUWERK Rechtsanwälte PartG mbB, Gänsemarkt 35, 20354 Hamburg, Germany www.neuwerk.legal